AssayIndex
SSA cross-section

SSA by compound

SSA records split by compound, with the index-wide comparison for the same compound beside each one. 30 compounds, 294 records. Cells below n=3 print their raw values instead of a median.

30 compounds294 records
CompoundClassReportsSSA median %Index median %Δ (pp)SpecPass %
RetatrutideIncretin3797.7398.41-0.6896.597
SemaglutideIncretin3698.2398.87-0.6497.0100
MOTS-cMetabolic2798.3399.18-0.8598.063
MazdutideIncretin1798.2998.11+0.1896.5100
L-Glutathione (reduced)Short1798.9999.00-0.0198.588
BPC-157Tissue-repair1598.9099.15-0.2598.087
TirzepatideIncretin1597.7198.44-0.7397.0100
IpamorelinGrowth-hormone1598.2399.48-1.2599.020
PEG-MGFGrowth-hormone1295.8697.92-2.0692.0100
TB-500Tissue-repair1298.5999.47-0.8898.558
LL-37Tissue-repair1298.3198.61-0.3196.5100
SemaxNeuroactive1198.3099.17-0.8798.518
VilonShort1199.1599.150.0099.082
IGF-1 DES (1-3)Growth-hormone999.2898.53+0.7595.0100
GlucagonIncretin7 n=798.9198.78+0.1398.071
GHRP-2Growth-hormone6 n=699.2299.22-0.0099.067
Melanotan IIMelanocortin-receptor6 n=698.5999.24-0.6598.550
SS-31 (Elamipretide)Metabolic5 n=597.7299.42-1.7098.50
Thymosin α1Tissue-repair4 n=498.6399.11-0.4897.5100
L-CarnosineShort3 n=398.4299.07-0.6599.033
GHK-CuTissue-repair2 n=2n<398.5497.0100
Enclomiphene citrateNon-peptide2 n=2n<399.2398.50
TriptorelinHypothalamic2 n=2n<398.4798.5100
CJC-1295 with DACGrowth-hormone2 n=2n<398.7997.5100
GonadorelinHypothalamic2 n=2n<399.2898.5100
PT-141 (Bremelanotide)Melanocortin-receptor2 n=2n<399.3198.50
Humanin (HNG)Metabolic2 n=2n<399.4797.5100
KPVTissue-repair1 n=1n<399.2199.0100
5-Amino-1MQNon-peptide1 n=1n<399.2498.0100
SermorelinGrowth-hormone1 n=1n<398.9498.0100
95.296.096.997.798.699.4100.3RetatrutideRetatrutide: Q1 97.37, median 97.73, Q3 98.38, n=37n=37SemaglutideSemaglutide: Q1 97.72, median 98.23, Q3 98.77, n=36n=36MOTS-cMOTS-c: Q1 97.84, median 98.33, Q3 99.16, n=27n=27MazdutideMazdutide: Q1 97.94, median 98.29, Q3 98.74, n=17n=17L-Glutathione (reduce…L-Glutathione (reduce…: Q1 98.78, median 98.99, Q3 99.36, n=17n=17BPC-157BPC-157: Q1 98.32, median 98.90, Q3 99.41, n=15n=15TirzepatideTirzepatide: Q1 97.53, median 97.71, Q3 98.06, n=15n=15IpamorelinIpamorelin: Q1 97.94, median 98.23, Q3 98.73, n=15n=15PEG-MGFPEG-MGF: Q1 95.69, median 95.86, Q3 96.07, n=12n=12TB-500TB-500: Q1 98.38, median 98.59, Q3 98.91, n=12n=12LL-37LL-37: Q1 97.97, median 98.31, Q3 98.66, n=12n=12SemaxSemax: Q1 98.19, median 98.30, Q3 98.44, n=11outlier 98.84outlier 99.12n=11VilonVilon: Q1 99.04, median 99.15, Q3 99.44, n=11outlier 98.42n=11IGF-1 DES (1-3)IGF-1 DES (1-3): Q1 98.94, median 99.28, Q3 99.68, n=9outlier 97.65n=9 Purity (% area)
Figure. Distribution per compound where n ≥ 4. Rows are ordered by coverage, not by result.